期刊文献+

神经母细胞瘤患儿那西妥单抗联合化疗的药学监护1例

Pharmacological monitoring of naxitamab combined with chemotherapy in a patient with neuroblastoma
原文传递
导出
摘要 该研究探讨了临床药师在1例复发神经母细胞瘤患儿使用那西妥单抗联合化疗方案中的药学监护。通过对患儿进行疼痛管理、化疗方案管理、那西妥单抗不良反应识别与监护、药物相互作用评估及持续药学监护,临床药师协助医生成功识别并管理药物相关不良反应,优化了治疗方案,为患儿提供了精细化的治疗保障,提高了治疗方案的有效性和安全性,提高了患儿的治疗依从性和生活质量,为类似病例的药学监护提供了宝贵经验。 The study investigated the role of clinical pharmacists in delivering pharmaceutical care to a pediatric patient with relapsed neuroblastoma and treated with a combined therapeutic regimen of naxitamab and chemotherapy.By implementing prehensive pain management,overseeing the chemotherapy regimen,identifying and monitoring naxitamab-related adverse reac-tions,evaluating potential drug interactions,and providing continuous pharmaceutical care,the clinical pharmacist collaborated with physicians to effectively identify and manage drug-related adverse effects,optimize the treatment strategy,and deliver person-alized therapeutic support.This multidisciplinary approach not only enhanced the efficacy and safety of the treatment,but also improved the patient's treatment adherence and overall quality of life.The findings offered valuable insights and practical guidance for pharmaceutical care in similar clinical scenarios.
作者 胡天骄 孙尧 李健 何璐璐 李涛 徐进 周莉 HU Tianjiao;SUN Yao;LI Jian;HE Lulu;LI Tao;XU Jin;ZHOU Li(Department of Pharmacy,Children's Hospital of Nanjing Medical University,Jiangsu Nanjing 210008,China;Department of Oncology,Children's Hospital of Nanjing Medical University,Jiangsu Nanjing 210008,China;Department of Hematology,Children's Hospital of Nanjing Medical University,Jiangsu Nanjing 210008,China)
出处 《中国医院药学杂志》 北大核心 2025年第11期1312-1315,共4页 Chinese Journal of Hospital Pharmacy
关键词 那西妥单抗 神经母细胞瘤 药品不良反应 药学监护 naxitamab neuroblastoma adverse drug reaction pharmaceutical care
作者简介 胡天骄,女,硕士研究生,主管药师,研究方向:肿瘤药学;通信作者:周莉,女,硕士研究生,主任医师,研究方向:肿瘤学。
  • 相关文献

参考文献4

二级参考文献6

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部